Sergey Rakhilin

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. ncbi Electrical impedance as a novel biomarker of myotube atrophy and hypertrophy
    Sergey Rakhilin
    Novartis Institute for Biomedical Research, Cambridge, MA, USA
    J Biomol Screen 16:565-74. 2011

Detail Information

Publications1

  1. ncbi Electrical impedance as a novel biomarker of myotube atrophy and hypertrophy
    Sergey Rakhilin
    Novartis Institute for Biomedical Research, Cambridge, MA, USA
    J Biomol Screen 16:565-74. 2011
    ..Application of this technique to drug screening might be beneficial in finding novel treatments preventing muscle atrophy and other diseases associated with any morphological change in cell shape...